|
1）Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004; 44: 1774-89
|
|
|
|
2）Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985; 25: 573-7
|
|
|
|
|
|
3）Toy P, Bacchetti P, Grimes B, et al. Recipient clinical risk factors predominate in possible transfusion-related acute lung injury. Transfusion. 2015; 55: 947-52
|
|
|
|
|
|
4）Muller MC, van Stein D, Binnekade JM, et al. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion. 2015; 55: 164-75
|
|
|
|
|
|
5）Schmickl CN, Mastrobuoni S, Filippidis FT, et al. Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review. Crit Care Med. 2015; 43: 205-25
|
|
|
|
|
|
6）Looney MR, Roubinian N, Gajic O, et al. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med. 2014; 42: 1676-87
|
|
|
|
|
|
7）Eder AF, Dy BA, Perez JM, et al. The residual risk of transfusion-related acute lung injury at the American Red Cross （2008-2011）: limitations of a predominantly male-donor plasma mitigation strategy. Transfusion. 2013; 53: 1442-9
|
|
|
|
|
|
8）Bayat B, Tjahjono Y, Sydykov A, et al. Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol. 2013; 33: 2538-48
|
|
|
|
|
|
9）Looney MR, Matthay MA. Animal models of transfusion-related acute lung injury. Crit Care Med. 2006; 34（5 Suppl）: S132-6
|
|
|
|
|
|
10）Okazaki H, Ishikawa O, Iijima T, et al. Novel swine model of transfusion-related acute lung injury. Transfusion. 2014; 54: 3097-107
|
|
|
|
|
|
11）Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury （TRALI）. Br J Haematol. 2007; 136: 788-99
|
|
|
|
|
|
12）Hashimoto S, Nakajima F, Kamada H, et al. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Transfusion. 2010; 50: 2582-91
|
|
|
|
|
|
13）Saw CL, Hannach B, Petrazsko T, et al. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors. Transfusion. 2012; 53: 518-25
|
|
|
|
|
|
14）Weber LL, Roberts LD, Sweeney JD. Residual plasma in red blood cells and transfusion-related acute lung injury. Transfusion. 2014; 54: 2425-30
|
|
|
|
|
|
15）Qing DY, Conegliano D, Shashaty MG, et al. Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation. Am J Respir Crit Care Med. 2014; 190: 1243-54
|
|
|
|
|
|
16）Popovsky MA, Audet AM, Andrzejewski C, Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematol. 1996; 12: 87-9
|
|
|
|
|
|
17）Plummer NS. Blood transfusion: a report of six fatalities. Br Med J. 1936; 2: 1186-9
|
|
|
|
|
|
18）Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2013. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm391574.htm
|
|
|
|
|
|
19）Murphy EL, Kwaan N, Looney MR, et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med. 2013; 126: 357 e29-38
|
|
|
|
|
|
20）Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012; 52: 160-5
|
|
|
|
|
|
21）Raval JS, Mazepa MA, Russell SL, et al. Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion. Vox Sang. 2015; 108: 387-92
|
|
|
|
|
|
22）Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides （brain natriuretic peptide and N-terminal pro-brain natriuretic） in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009; 49: 13-20
|
|
|
|
|
|
23）Andrzejewski C Jr, Popovsky MA, Stec TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion. 2012; 52: 2310-20
|
|
|
|
|
|
24）Blumberg N, Heal JM, Gettings KF, et al. An association between decreased cardiopulmonary complications （transfusion-related acute lung injury and transfusion-associated circulatory overload） and implementation of universal leukoreduction of blood transfusions. Transfusion. 2010; 50: 2738-44
|
|
|
|
|
|
25）Roubinian NH, Looney MR, Kor DJ, et al. Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions. Transfusion. 2015; 55: 1838-46
|
|
|
|
|